[Asymptomatic electrocardiographic abnormalities during antiblastic chemotherapy].
In patients under antiblastic treatment electrocardiographic abnormalities without subjective symptomatology were observed. The genesis of these abnormalities is discussed in the light of wath is known from the literature. Periodical electrocardiographic control of patients treated with antiblastic drugs is highly recommended.
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D001943:Breast Neoplasms / Q000188:drug therapy; D005117:Cardiac Complexes, Premature / Q000139:chemically induced; D003520:Cyclophosphamide / Q000627:therapeutic use; D004562:Electrocardiography; D004938:Esophageal Neoplasms / Q000188:drug therapy; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000188:drug therapy; D013629:Tamoxifen / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013629:Tamoxifen; D014750:Vincristine; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Anomalie elettrocardiografiche asintomatiche in corso di chemioterapia antiblastica.